EX-99.1 7 ex991_1.htm EXHIBIT 99.1

 

 Exhibit 99.1Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



Exenatide implant reduces liver fat by 82% in obese mice after 12 weeks​ Liver fat reduction in high fat diet-induced obese mice. Liver fat % area for exenatide implant vs sham implant 12 weeks after a single administration. Liver fat % area is calculated using Oil Red O (ORO) staining. Values are mean ± SE. These results are numerically consistent with a similar investigation in which liver fat content was evaluated in high fat diet-induced obese mice that received semaglutide injections.​;

 Graphics



Exenatide delivered with NanoPortal™ technology is associated with durable body weight effects​ Weight difference from control in healthy Sprague-Dawley Rats. % weight change from baseline for a single administration of exenatide implant in a study associated with NPM-119 (~320 nmol/kg/day) corrected to control (vehicle implant). (A) All animals measured through 105 days of treatment; (B) 5 animals measured in each group through 112 days of treatment followed by a 28-day recovery period. Values are mean ± SE. ​;

 Graphics



 

 Graphics



 


Graphics



 


Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics



 

 Graphics